Search

Your search keyword '"Ophthalmic drugs -- Usage"' showing total 3 results
Start Over Descriptor "Ophthalmic drugs -- Usage" Journal business wire
3 results on '"Ophthalmic drugs -- Usage"'

1. Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses

Subjects
Allergan Inc., Pharmaceutical industry -- Health aspects, Botulinum toxin -- Usage, Botulinum toxin -- Health aspects, Ophthalmic drugs -- Usage, Ophthalmic drugs -- Health aspects, Business, Business, international
Abstract

IRVINE, Calif. -- Allergan, Inc. (NYSE: AGN) today announced that it received a subpoena from the United States Department of Justice, United States Attorney's Office for the Northern District of [...]

Published
2008

2. Commenting on the U.S. Food and Drug Administration (FDA) Early Communication, Allergan Clarifies FDA's Inquiry Relates Primarily to High Dose Medical Uses of BOTOX(R), Rather Than BOTOX(R) Cosmetic for Aesthetic Use

Subjects
Allergan Inc. (Irvine, California), Botulinum toxin -- Usage, Ophthalmic drugs -- Usage, Pharmaceutical industry -- Usage, Business, Business, international
Abstract

IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today commented on and provided support for the U.S. Food and Drug Administration's (FDA) 'Early Communication' regarding a safety review of botulinum toxins in [...]

Published
2008

3. Allergan Announces FDA Approval of LUMIGAN(R) as First-Line Treatment for Elevated Eye Pressure in Open-Angle Glaucoma; Indication Expands Approved Uses of LUMIGAN(R) in the Management of Glaucoma

Subjects
Allergan Inc., Hypertension -- Drug therapy, Ophthalmic drugs -- Usage, Pharmaceutical industry, Executives, Drug approval, Business, Business, international
Abstract

IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today announced that the United States Food and Drug Administration (FDA) has approved Allergan's once-daily prescription eye drop LUMIGAN(R) (bimatoprost ophthalmic solution) 0.03% as [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results